# Study Of Tranexamic Acid For The Reduction Of Blood Loss In Patients Undergoing Major Abdominal Surgery

> **NCT00827931** · PHASE4 · COMPLETED · sponsor: **Pfizer** · enrollment: 94 (actual)

## Conditions studied

- Biliary Tract Surgical Procedures
- Pancreaticoduodenectomy
- Esophagectomy
- Colectomy
- Gastrectomy

## Interventions

- **DRUG:** Tranexamic acid + Standard of Care
- **PROCEDURE:** Standard of Care

## Key facts

- **NCT ID:** NCT00827931
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-09
- **Primary completion:** 2011-04
- **Final completion:** 2011-05
- **Target enrollment:** 94 (ACTUAL)
- **Last updated:** 2012-04-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00827931

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00827931, "Study Of Tranexamic Acid For The Reduction Of Blood Loss In Patients Undergoing Major Abdominal Surgery". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT00827931. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*